Skip to content

Clinical trials

Pediatric Obesity trials in Canada with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pediatric Obesity Phase: Not applicable Country / region: Canada Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20103
20111
20133
20145
20151
20162
20172
20185
20192
20201
20213
20222
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Unknown status5
Terminated2
Recruiting2
Not yet recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Hospital for Sick Children9
University of Alberta6
Toronto Metropolitan University3
University of British Columbia3
Hamilton Health Sciences Corporation2
University of Toronto2
University of Victoria2
Duke University1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
McGill University Health Centre/Research Institute of the McGill University Health Centre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pediatric Obesity37
Obesity14
Diabetes Mellitus, Type 22
Tooth Wear2
Body Weight1
Chronic Disease1
Fatty Liver1
Glucose Intolerance1
Glucose Metabolism Disorders1
Insulin Resistance1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.